Medication-Assisted Treatment Use Among Pregnant Women With Opioid Use Disorder.

ABSTRACT:

Objective

To evaluate temporal trends in medication-assisted treatment use among pregnant women with opioid use disorder.

Methods

We conducted a retrospective cohort study using Pennsylvania Medicaid administrative data. Trends in medication-assisted treatment use, opioid pharmacotherapy (methadone and buprenorphine) and behavioral health counselling, were calculated using pharmacy records and procedure codes. Cochrane-Armitage tests evaluated linear trends in characteristics of pregnant women using methadone compared with buprenorphine.

Results

In total, we evaluated 12,587 pregnancies among 10,741 women with opioid use disorder who had a live birth between 2009 and 2015. Across all years, 44.1% of pregnant women received no opioid pharmacotherapy, 27.1% used bupreno

SUBMITTER: Krans EE 

PROVIDER: S-EPMC6483844 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature